What do we know about canine osteosarcoma treatment? – review

Alvarez FJ, Kisseberth W, Hosoya K et al (2014) Postoperative adjuvant combination therapy with doxorubicin and noncytotoxic suramin in dogs with appendicular osteosarcoma. J Am Anim Hosp Assoc 50(1):12–18. doi: 10.5326/JAAHA-MS-5958

Bacon NJ, Ehrhart NP, Dernell WS et al (2008) Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999–2006). J Am Vet Med Assoc 232(10):1504–1510. doi: 10.2460/javma.232.10.1504

Batschinski K, Dervisis NG, Kitchell BE (2012) Evaluation of ifosfamide salvage therapy for metastatic canine osteosarcoma. Vet Comp Oncol. doi: 10.1111/j.1476-5829.2012.00355.x

Berg J (1996) Canine osteosarcoma: amputation and chemotherapy. Vet Clin North Am Small Anim Pract 26(1):111–121

Berg J, Weinstein MJ, Schelling SH et al (1992) Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987–1990). J Am Vet Med Assoc 200(12):2005–8

Berg J, Weinstein MJ, Springfield DS et al (1995) Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma. J Am Vet Med Assoc 206(10):1555–1560

Bergman PJ, MacEwen EG, Kurzman ID et al (1996) Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993). J Vet Intern Med 10(2):76–81

Boston SE, Ehrhart NP, Dernell WS et al (2006) Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985–2004). J Am Vet Med Assoc 228(12):1905–1908

Brodey RS (1979) The use of naturally occurring cancer in domestic animals for research into human cancer: general considerations and a review of canine skeletal osteosarcoma. Yale J Biol Med 52:345–361

Brodey RS, Abt DA (1976) Results of surgical treatment in 65 dogs with osteosarcoma. J Am Vet Med Assoc 168(11):1032–1035

Cavalcanti JM,Amstalden EMI, Guerra JL, Magna LC (2004) Osteosarcoma in dogs: clinical-morphological study and prognostic correlation. Braz J Vet Res Anim Sci 41(5). http://dx.doi.org/10.1590/S1413-95962004000500002

Chun R, Kurzman ID, Couto CG, Klausner J et al (2000) Cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma: a pilot study. J Vet Intern Med 14(5):495–498

Cooley DM, Beranek BC, Schlittler DL et al (2002) Endogenous gonadal hormone exposure and bone sarcoma risk. Cancer Epidemiol Biomarkers Prev 11(11):1434–1440

Covey JL, Farese JP, Bacon NJ et al (2014) Stereotactic radiosurgery and fracture fixation in 6 dogs with appendicular osteosarcoma. Vet Surg 43(2):174–181

Hahn KA, Richardson RC, Blevins WE et al (1996) Intramedullary cisplatin chemotherapy: experience in four dogs with osteosarcoma. J Small Anim Pract 37((4):187–192

Hillers KR, Dernell WS, Lafferty MH, Withrow SJ (2005) Lana SE (2005) Incidence and prognostic importance of lymph node metastases in dogs with appendicular osteosarcoma: 228 cases (1986–2003). J Am Vet Med Assoc 226(8):1364–1367

Jehn CT, Lewis DD, Farese JP et al (2007) Transverse ulnar bone transport osteogenesis: a new technique for limb salvage for the treatment of distal radial osteosarcoma in dogs. Vet Surg 36(4):324–334

Jongeward SJ (1985) Primary bone tumors. Vet Clin N Am Small Anim Pract 15:609–641

Kent MS, Strom A, London CA, Seguin B (2004) Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs. J Vet Intern Med 18(4):540–544

Kimura R, Rokkaku T, Takeda S et al (2013) Cytotoxic effects of fucoidan nanoparticles against osteosarcoma. Mar Drugs 11(11):4267–4278

Kirpensteijn J, Teske E, Kik M et al (2002) Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluation. Anticancer Res 22(5):2765–2770

Kozicki AR, Robat C, Chun R, Kurzman ID (2013) Adjuvant therapy with carboplatin and pamidronate for canine appendicular osteosarcoma. Vet Comp Oncol. 2013 May 10

Kraegel SA, Madewell BR, Simonson E (1991) Gregory CR (1991) Osteogenic sarcoma and cisplatin chemotherapy in dogs: 16 cases (1986–1989). J Am Vet Med Assoc 199(8):1057–1059

Kurzman ID, MacEwen EG, Rosenthal RC et al (1995) Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin. Clin Cancer Res 1(12):1595–1601

Lane A, Black M, Wyatt K (2012) Toxicity and efficacy of a novel doxorubicin and carboplatin chemotherapy protocol for the treatment of canine appendicular osteosarcoma following limb amputation. Aust Vet J 90(3):69–74

Langenbach A, Anderson MA, Dambach DM et al (1998) Extraskeletal osteosarcomas in dogs: a retrospective study of 169 cases (1986–1996). J Am Anim Hosp Assoc 34(2):113–120

Liptak JM, Dernell WS, Ehrhart N et al (2006) Cortical allograft and endoprosthesis for limb-sparing surgery in dogs with distal radial osteosarcoma: a prospective clinical comparison of two different limb-sparing techniques. Vet Surg 35(6):518–533

MacDonald TL, Schiller TD (2010) Limb-sparing surgery using tantalum metal endoprosthesis in a dog with osteosarcoma of the distal radius. Can Vet J 51(5):497–500

MacEwen EG, Kurzman ID (1996) Canine osteosarcoma: amputation and chemoimmunotherapy. Vet Clin North Am Small Anim Pract 26(1):123–133

Mauldin GN, Matus RE, Withrow SJ et al (1988) Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin. J Vet Intern Med 2(4):177–180

McMahon M, Mathie T, Stingle N et al (2011) Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma. J Vet Intern Med 25(3):511–517

Mehl ML, Withrow SJ, Seguin B et al (2001) Spontaneous regression of osteosarcoma in four dogs. J Am Vet Med Assoc 219(5):614–617

Moore AS, Dernell WS, Ogilvie GK et al (2007) Doxorubicin and BAY 12–9566 for the treatment of osteosarcoma in dogs: a randomized, double-blind, placebo-controlled study. J Vet Intern Med 21(4):783–790

Morello E, Martano M, Buracco P (2011) Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma. Vet J 189(3):268–277

Oblak ML, Boston SE, Higginson G et al (2012) The impact of pamidronate and chemotherapy on survival times in dogs with appendicular primary bone tumors treated with palliative radiation therapy. Vet Surg 41(3):430–435

O’Brien MG, Straw RC, Withrow SJ et al (1993) Resection of pulmonary metastases in canine osteosarcoma: 36 cases (1983–1992). Vet Surg 22(2):105–109

Ogilvie GK, Straw RC, Jameson VJ et al (1993) Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastasis in dogs: 45 cases (1987–1991). J Am Vet Med Assoc 202(2):304–306

Phillips B, Powers BE, Dernell WS et al (2009) Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. J Am Anim Hosp Assoc 45(1):33–38

Pool RR (1990) Tumors of bone and cartilage. In: Tumors in Domestic Animals (3rd Edit) JE Moulton (Ed.), University of California press, Berkeley (1990), pp.157–230

Saam DE, Liptak JM, Stalker MJ et al (2011) Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996–2006). J Am Vet Med Assoc 238(2):195–206

Schmidt AF, Nielen M, Klungel OH et al (2013) Prognostic factors of early metastasis and mortality in dogs with appendicular osteosarcoma after receiving surgery: an individual patient data meta-analysis. Prev Vet Med 112(3–4):414–422

Selmic LE, Burton JH, Thamm DH et al (2014) Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med 28(2):554–563

Selvarajah GT, Kirpensteijn J (2010) Prognostic and predictive biomarkers of canine osteosarcoma. Vet J 185(1):28–35

Sha B, Gao W, Han Y et al (2013) Potential application of titanium dioxide nanoparticles in the prevention of osteosarcoma and chondrosarcoma recurrence. J Nanosci Nanotechnol 13(2):1208–1211

Simcock JO, Withers SS, Prpich CY et al (2012) Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006–2010). J Am Vet Med Assoc 24(5):608–614

Spodnick GJ, Berg J, Rand WM et al (1992) Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978–1988. J Am Vet Med Assoc 200(7):995–999

Skorupski KA, Uhl JM, Szivek A, Allstadt Frazier SD, Rebhun RB, Rodriguez CO Jr (2013) Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial. Vet Comp Oncol. doi: 10.1111/vco.12069

Straw RC, Withrow SJ (1996) Limb-sparing surgery versus amputation for dogs with bone tumors. Vet Clin North Am Small Anim Pract 26(1):135–143

Straw RC, Withrow SJ, Richter SL et al (1991) Amputation and cisplatin for treatment of canine osteosarcoma. Vet Intern Med 5(4):205–210

Susa M, Iyer AK, Ryu K, Choy E, Hornicek FJ, Mankin H, Milane L, Amiji MM, Duan Z (2010) Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. PLoS ONE 5(5):e10764. doi: 10.1371/journal.pone.0010764

Thompson RR, Pool KG (2002) Tumors of bones p. In: Meuten DJ (ed) Tumors in domestic animals, 4th edn. Iowa State Press, Ames, pp 245–318

Trost ME, Kommers GD, Brown CC et al (2012) Primary bone neoplasms in dogs: 90 cases. Pesq Vet Bras 32(12):1329–1335

Vail DM, Kurzman ID, Glawe PC et al (2002) STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial. Cancer Chemother Pharmacol 50(2):131–136

Withrow SJ, Vail DM, Page RL (2013) “Withrow and MacEven’s small animal clnical oncology” 5th ed. Mosby Elsevier